Topical infliximab

( DrugBank: Infliximab / KEGG DRUG: Infliximab )


3 diseases
IDDisease name (Link within this page)Number of trials
38Stevens-Johnson syndrome1
39Toxic epidermal necrolysis1
IDDisease name (Link within this page)Number of trials
162Pemphigoid1

38. Stevens-Johnson syndrome


Clinical trials : 19Drugs : 25 - (DrugBank : 10) / Drug target genes : 14 - Drug target pathways : 98 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

39. Toxic epidermal necrolysis


Clinical trials : 15Drugs : 16 - (DrugBank : 9) / Drug target genes : 10 - Drug target pathways : 99 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

162. Pemphigoid


Clinical trials : 128Drugs : 108 - (DrugBank : 49) / Drug target genes : 35 - Drug target pathways : 143 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries